HMOX1 and Hyperbilirubinemia: A study also discovered that Sn-PP can traverse both the placental barrier and blood-brain barrier of neonates, inhibiting tissue HO activity in fetus and brain HO in neonates respectively, and thereby following such prenatal administration, suppresses postnatal hyperbilirubinemia [17].